Aflac (NYSE:AFL) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS

Aflac (NYSE:AFL - Get Free Report) announced its quarterly earnings results on Wednesday. The financial services provider reported $1.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.80 by ($0.05), FiscalAI reports. The firm had revenue of $4.35 billion for the quarter, compared to analyst estimates of $4.20 billion. Aflac had a net margin of 25.60% and a return on equity of 14.07%. The firm's quarterly revenue was up 27.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.66 earnings per share.

Aflac Stock Performance

NYSE:AFL opened at $113.62 on Friday. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.29. The stock has a market capitalization of $58.53 billion, a P/E ratio of 12.90, a price-to-earnings-growth ratio of 3.19 and a beta of 0.66. The firm has a 50 day moving average of $111.37 and a 200-day moving average of $110.84. Aflac has a 1 year low of $96.95 and a 1 year high of $119.32.

Key Aflac News

Here are the key news stories impacting Aflac this week:

• Positive Sentiment: Aflac is targeting higher Japan sales (near JPY 80 billion) and is expanding its reinsurance franchise in Japan — a strategic push that could lift long‑term growth and margins in its largest market. Aflac targets Japan sales closer to JPY 80B while expanding reinsurance franchise in Japan
• Positive Sentiment: Top‑line beat and strong growth: Q1 revenue rose roughly 28% YoY to about $4.3B, driven by U.S. growth and higher sales overall — supports the company’s revenue momentum despite other headwinds. Aflac Incorporated Announces First Quarter 2026 Results
• Neutral Sentiment: Mixed earnings print: management reported EPS of $1.75 (slightly below consensus) while revenue beat — a mixed signal that explains volatility. Investors will parse whether the EPS miss reflects one‑time items, FX, or operating trends. Aflac Incorporated Q1 2026 Earnings Call Summary
• Neutral Sentiment: Full earnings call transcript is available for details on management commentary and capital allocation (helpful for investors assessing buybacks/dividends/reinsurance strategy). Aflac (AFL) Q1 2026 Earnings Call Transcript
• Negative Sentiment: Currency headwind: a weaker yen vs. dollar noticeably reduced reported earnings, a key reason the stock is under pressure despite strong local results in Japan. FX sensitivity remains a near‑term risk. Aflac stock slides as weaker yen/dollar exchange rate impacts Q1 earnings
• Negative Sentiment: Small EPS misses and some analyst caution: several outlets flagged the EPS shortfall vs. estimates, which has led to mixed analyst reactions and near‑term downward pressure on the stock. Aflac (AFL) Q1 Earnings and Revenues Miss Estimates
• Negative Sentiment: Significant insider and institutional selling activity has been reported, which can weigh on sentiment even as fundamentals evolve. AFLAC ($AFL) Releases Q1 2026 Earnings

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on AFL shares. Keefe, Bruyette & Woods raised their price objective on shares of Aflac from $113.00 to $115.00 and gave the company a "market perform" rating in a research report on Friday, April 10th. Mizuho set a $102.00 target price on shares of Aflac and gave the stock an "underperform" rating in a research report on Monday, April 13th. Evercore upgraded shares of Aflac from a "strong sell" rating to a "strong-buy" rating in a research note on Thursday, April 9th. Piper Sandler upgraded shares of Aflac to a "strong-buy" rating in a report on Thursday, April 2nd. Finally, Barclays set a $99.00 price objective on shares of Aflac and gave the company an "underweight" rating in a research note on Thursday. Two investment analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $111.64.

Insider Buying and Selling at Aflac

In other news, major shareholder Post Holdings Co. Ltd. Japan sold 86,155 shares of the business's stock in a transaction on Thursday, April 9th. The stock was sold at an average price of $113.24, for a total transaction of $9,756,192.20. Following the completion of the sale, the insider owned 51,636,945 shares in the company, valued at $5,847,367,651.80. The trade was a 0.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 572,632 shares of company stock valued at $63,514,634 over the last three months. Company insiders own 0.80% of the company's stock.

Institutional Investors Weigh In On Aflac

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Quarry LP acquired a new position in shares of Aflac during the 4th quarter worth approximately $25,000. Darwin Wealth Management LLC bought a new stake in Aflac during the 2nd quarter worth $33,000. Birchwood Financial Partners Inc. bought a new position in Aflac in the fourth quarter valued at about $36,000. Ankerstar Wealth LLC bought a new position in Aflac in the fourth quarter valued at about $48,000. Finally, Headlands Technologies LLC acquired a new stake in shares of Aflac during the second quarter valued at about $67,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Aflac Company Profile

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac's product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.